Quidel | QDEL - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
Abbott USD 9.21B 17M 2025-12
Agilent USD 1.44B 27M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bruker USD 900.9M 124.3M 2025-12
Cerus USD 34.78M 2.98M 2024-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Danaher USD 5.34B 45.74B 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
Hologic USD 349.4M 447.1M 2025-12
Illumina USD 903M 69M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
Neogen USD 230.07M 4.79M 2025-09
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quidel USD 760.9M 1.28B 2025-12
Revvity USD 626.22M 25.62M 2025-12
STAAR Surgical USD 68.74M 1.55M 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Waters USD 661.85M 1.67B 2025-12